IP Verse

Heterodimers Of Glutamic Acid

PatentPatent Analysis

EP3335736

MOLECULAR INSIGHT PHARMACEUTICALS
Application Number
EP18150494A
Filing Date
Nov 7, 2007
Status
Revoked
Jun 24, 2022
Grant Date
Dec 30, 2020
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3699162B1

Bibliography

The patent EP3335736B1 was granted to Molecular Insight Pharmaceuticals on Dec 30, 2020 following the initial filing on Nov 7, 2007 under the application number EP18150494A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTS UNIVERSITAT HEIDELBERGSep 30, 2021ADMISSIBLE
POLSERVICE KANCELARIA RZECZNIKOW PATENTOWYCH SP Z OOSep 30, 2021ADMISSIBLE
LEWIS SILKINSep 23, 2021WITHDRAWN

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents